The current status and future directions of myxoma virus, a master in immune evasion
2011
Myxoma Virus: Immune Evasion and Future Directions
publication
Evidence: moderate
Author Information
Author(s): Bart Spiesschaert, Grant McFadden, Katleen Hermans, Hans Nauwynck, Gerlinde Van de Walle
Primary Institution: Ghent University
Conclusion
Myxoma virus has significant potential in both controlling rabbit populations and treating human diseases due to its immune-modulating properties.
Supporting Evidence
- MYXV has been used to control rabbit populations in Australia.
- Certain MYXV proteins are being developed to treat human inflammatory diseases.
- MYXV can selectively infect and kill human cancer cells.
Takeaway
Myxoma virus can make rabbits very sick, but scientists are also looking at how it can help treat diseases in people, like cancer.
Limitations
The study does not provide specific experimental data or sample sizes, limiting the ability to draw definitive conclusions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website